Case File
efta-efta00878993DOJ Data Set 9OtherDS9 Document EFTA00878993
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00878993
Pages
1
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To: Jeffrey Epstein [email protected]>
Subject: FW: Concept Note - The Neonatal Septisome
Date: Thu, 24 Feb 2011 22:38:20 +0000
Attachments: Concept_Note_Neonatal_Septisome_022411.pdf
Interested?
A bunch of super crazy neurosurgeons. A little would go a long way. They are at Harvard and a few other places.
Original Message
From: Steven Schiff [mailto:
Sent: Thursda February 24, 2011 12:13 PM
To:
Cc: Schiff Steven; Benjamin Warf; Greg Lucier,
Subject: Concept Note - The Neonatal Septisome
Dear
The World Health Organization estimates that 1.6 million neonates die of infection each year, and almost half of
these cases of neonatal sepsis (NS) occur in sub-Saharan Africa. We have uncovered the magnitude of the
neurological burden in survivors of NS, postinfectious hydrocephalus (PIH), which has not been appreciated by
the global health community. The brains of children with PIH are devastated, with new estimates in sub-Saharan
Africa of human capital lost of $1.2-1.4 billion, and the values of statistical lives lost of $2648 billion per year.
The potential economic benefits from a modest reduction of such cases would be extraordinary, and solid
medical investigation would lead to prevention of the majority of these cases. PIH and other severe sequelae are
generated from inadequately treated NS. If we knew the organisms that caused NS, we could both design
inexpensive point-of-treatment diagnostics to optimize therapy, and institute public health preventative strategies
to decrease the incidence of NS. But we don't know the majority of agents - and they will be geographically and
seasonally distinct. We wish to dramatically affect this situation in the near term with a 4-pronged approach: 1)
define and predict the neonatal Septisome, 2) optimize treatment of NS in a sustainable fashion to reduce serious
sequelae such as brain damage, 3) institute cost-effective rational public health and vaccination strategies for
prevention of NS, and 4) develop a template for instituting 1-3 sustainably in other developing countries.
We have attached a Concept Note expanding on these ideas for your consideration.
With our best regards,
Steve and Ben
Steven J. Schiff, MD, PhD
Brush Chair Professor of Engineering
Director, Center for Neural Engineering
Penn State University
http://www.esm.psu.edu/schiff
Benjamin C. Warf MD
Director, Neonatal and Congenital Anomaly Neurosurgery Department of Neurosurgery Children's Hospital
Boston Harvard Medical School
EFTA00878993
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
http://www.esm.psu.edu/schiffRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.